Corvese Brian - Insider Non-Derivative Transactions at MiNK Therapeutics, Inc. (INKT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Corvese Brian's relationship to MiNK Therapeutics, Inc. (INKT) is Director, and currently has 50,053 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other INKT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Corvese Brian - Insider Non-Derivative Transactions of INKT Common Stock

Corvese Brian - Insider Non-Derivative Transactions at INKT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Acquisition -- (Common Stock)	1612	11.09	50053
Sep 3, 2025	Acquisition -- (Common Stock)	1290	13.86	48441
Jun 3, 2025	Acquisition -- (Common Stock)	2494	7.17	47151
Mar 4, 2025	Acquisition -- (Common Stock)	2033	8.79	44657
Dec 2, 2024	Acquisition -- (Common Stock)	24400	0.73	426283
Sep 4, 2024	Acquisition -- (Common Stock)	21802	0.82	405296
Jun 4, 2024	Acquisition -- (Common Stock)	17967	0.99	383494
Mar 2, 2024	Acquisition -- (Common Stock)	18816	0.95	365527
Dec 2, 2023	Acquisition -- (Common Stock)	17188	1.04	346711
Sep 2, 2023	Acquisition -- (Common Stock)	12244	1.46	329523
Jun 2, 2023	Acquisition -- (Common Stock)	10157	1.76	317505
Mar 2, 2023	Acquisition -- (Common Stock)	8553	2.09	307348